Sant Cugat del Valles, Spain

Ricard Mis Vizcaino


Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ricard Mis Vizcaino: Innovator in Glucosamine Salts Preparation

Introduction

Ricard Mis Vizcaino is a notable inventor based in Sant Cugat del Valles, Spain. He has made significant contributions to the field of biochemistry, particularly in the preparation of glucosamine salts. His innovative approach has led to advancements in therapeutic applications.

Latest Patents

Ricard holds a patent for a process for the preparation of glucosamine salts. This invention relates to the production of glucosamine sulfate, glucosamine hydroiodide, glucosamine pyruvate, glucosamine phosphate, or their mixtures with glucosamine hydrochloride through electrodialysis. The process involves the exchange of chloride ions for anions selected from a specific group during the electrodialysis process. The electrodialyser used in this method comprises a cathode, anode, and separation means, which can include anion exchange membranes, cation exchange membranes, or bipolar membranes. This invention also encompasses a glycosamine sulfate containing chlorides that can be obtained through this process, along with its therapeutic uses.

Career Highlights

Ricard is currently associated with Bioiberica, S.A., a company known for its focus on biopharmaceuticals and health products. His work has contributed to the development of innovative solutions in the field of glucosamine and its applications.

Collaborations

Throughout his career, Ricard has collaborated with notable colleagues, including Francisco Javier Vila Pahi and Ramon Ruhi Roura. These collaborations have fostered a productive environment for innovation and research.

Conclusion

Ricard Mis Vizcaino's contributions to the preparation of glucosamine salts highlight his role as an innovator in biochemistry. His patent and work at Bioiberica, S.A. demonstrate his commitment to advancing therapeutic applications in health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…